Compare ServiceNow Inc (NOW) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ServiceNow Inc vs Repligen Corporation Common Stock — how do they compare? ServiceNow Inc trades at $139.37 (market cap $143.30B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: ServiceNow Inc is far larger — about 12.9× Repligen Corporation Common Stock's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, ServiceNow Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ServiceNow Inc for 54 Days and Repligen Corporation Common Stock for 0 Days on average.
| NOW | RGEN | |
|---|---|---|
Market Cap | $143.30B | $11.14B |
Volume | 13,207,010 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $189.26 | $194.57 |
52-Week Low | $83.00 | $102.87 |
Typical Hold Time | 54 Days | 0 Days |
Enterprise Value | $147.09B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ServiceNow (NOW) trades at $138.61, down 1.22% on the day, amid a bullish technical setup with strong analyst support. The stock shows robust fundamentals with revenue growth from $7.2B in 2022 to $13.3B in 2025, a high gross margin of 74.77%, and consistent earnings beats. Recent news highlights AI-driven momentum, with AI annual contract value surpassing $1B in Q2 2026, fueling positive sentiment despite premium valuations.
The outlook remains positive given AI adoption and earnings strength, but risks include stiff competition and high P/E of 86.63. With 87% of analysts rating it Buy and a consensus target of $150.74, the stock offers upside, though investors should weigh valuation concerns against growth prospects.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
